F. Potvin et al., MECHANISMS OF ACTION OF ANTIMALARIALS IN INFLAMMATION - INDUCTION OF APOPTOSIS IN HUMAN ENDOTHELIAL-CELLS, The Journal of immunology, 158(4), 1997, pp. 1872-1879
Antimalarials are beneficial therapeutic agents in systemic lupus and
rheumatoid arthritis. These autoimmune diseases have abnormally low ap
optosis of inflammatory cells. Both disorders have an abnormal angioge
nesis. In the present report, antimalarials were demonstrated to selec
tively increase apoptosis of HUVECs in vitro. A 24-h exposure to 50 or
150 mu M of the drugs was associated with a significant loss of subst
rate-adherent cells. Chloroquine exhibited an inhibitory effect on HUV
EC proliferation over 7 days. Programmed cell death in HUVECs rendered
nonadherent by chloroquine was confirmed by the induction of DNA frag
mentation in floating cells. Northern blot analysis revealed a rapidly
increased expression of the bcl-x(s) gene without any change in the e
xpression of the bcl-2 gene, indicating that HUVECs under chloroquine
were undergoing apoptosis. The onset of the apoptotic cascade in HUVEC
s appeared shortly after the addition of chloroquine. The effect of ch
loroquine on apoptosis was distinct from acute cell lysis and was rest
ricted to HUVECs. Antimalarials also induced IL-1 alpha production. In
parallel, chloroquine alone did not increase the expression of IL-6.
Anti-IL-1 alpha Ab or IL-1Ra only marginally reversed chloroquine-indu
ced depression of proliferation for the low drug concentration, but no
t the massive cell death effect at and above 50 mu M. Taken together,
these data may indicate that antimalarials repress angiogenesis. The a
utocrine mechanism involving IL-1 alpha accounts only for a minor frac
tion of the full antiendothelial effect of chloroquine, which is mainl
y dependent on apoptosis.